CIMPRESS PLC

NASDAQ:CMPR
Annual Meeting

of Shareholders

MEETING DATE

12/08/2026
DEF 14A FILED
10/27/2026
PUBLISHED
10/27/2026 9:16 pm
TIME TO PUBLISH
10/29/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CMPR · CUSIP G2143T103 · CLASS ordinary shares · CIK 0001262976

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
1
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Reappoint Sophie A. Gasperment to our Board of Directors to serve for a term of three years ending at the conclusion of our annual general meeting of shareholders in 2029
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states Ms. Gasperment brings leadership, consumer brand-building, digital transformation, and public company board experience.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approve, on a non-binding, advisory basis, the compensation of our named executive officers, as described in this proxy statement
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Compensation Committee considered the most recent shareholder advisory vote on executive compensation at the 2025 annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Renew the authority of our Board of Directors, until June 8, 2028, to issue authorized but unissued ordinary shares of Cimpress plc up to a maximum of 20% of our issued and outstanding share capital
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The renewed authority is limited to 20% of outstanding ordinary shares and expires 18 months after the meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Renew the authority of our Board of Directors, until June 8, 2028, to opt out of statutory preemption rights under Irish law with respect to the issuance of ordinary shares for cash, up to a maximum of 20% of our issued and outstanding share capital
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the proposal would permit cash share issuances without statutory preemption rights.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Reappoint PricewaterhouseCoopers Ireland as our statutory auditor under Irish law to hold office until the conclusion of our annual general meeting of shareholders in 2027
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee recommended PricewaterhouseCoopers Ireland, and the filing states services followed pre-approval policies.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Authorize our Board of Directors or Audit Committee to determine the remuneration of PricewaterhouseCoopers Ireland in its capacity as our statutory auditor under Irish law
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

Irish law requires statutory auditor remuneration be fixed by shareholders or determined in a general meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

85ab43b38957cfbd831558bb4acbca450f16ac77106738b65a055d7c4b3fb2b2

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates